Neurology® Podcast

Pharmacy Benefits and Disease-Modifying Therapies

20 min • 14 februari 2022

Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple sclerosis. Read the full article in Neurology: Clinical Practice.

Senaste avsnitt

Podcastbild

00:00 -00:00
00:00 -00:00